newswire, breaking biotechnology and pharma news

Wednesday, November 10, 2010

Biotech/Pharma Stocks News; UV Flu Technologies (OTCBB: UVFT) ViraTech UV-400 Featured This Weekend on Nationally Televised Designing Spaces "Holiday Spaces" Show

CENTERVILLE, MA � November 10, 2010 ( Newswire) - UV Flu Technologies, Inc. (OTCBB: UVFT) (the "Company") is pleased to announce that the Company's ViraTech UV-400 air purifier technology is featured during "Designing Spaces-Innovations for a Healthy Home this Holiday Season," scheduled to air on Women's Entertainment (WeTV) this Friday, November 12th, at 9:30 am, EST, and again at the same hour on Sunday the 14th and Monday the 15th.
"I was very excited to participate on the show, particularly with Dr. Dennis Rosen, a Director of our Company and one of the foremost Pediatricians in the country today, as well as a real advocate for issues affecting children's health," said Jack Lennon, President of UV Flu Technology. "We hope to educate the public on the dangers associated with poor indoor air quality at every opportunity, as we believe it contributes to tens of thousands of deaths and billions of dollars of health care and lost work expenditures every year. We also wanted to inform and educate the public of the hazards posed though the use of existing filter based products on the market today that can cause serious illness if the filters or the electrostatic plates are not changed or cleaned on a constant basis."
"Our ViraTech UV-400 was developed in part as a response to the filter issue as it has no filters to change or plates to clean and kills airborne bacteria and other organic contaminants for years with virtually no maintenance. As Dr. Rosen states on the show, Doctors have become reluctant to recommend air purifiers principally because the public was found to not regularly maintain their filter products as required, which led to many of their patients suffering from additional symptoms and increased instances of illness. Our product overcomes these shortcomings and that is why Designing Spaces thought it would be the perfect product to feature in order to help keep families healthy over the Holidays, and far into the future," said Mr. Lennon.
For those who miss the television broadcast, the segment will available for viewing next week at:
Further details regarding the Company's business, financial reports and agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database.
About UV Flu Technologies, Inc. (OTC.BB:UVFT)
UV Flu Technologies is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector (over $7.7 billion in 2008). The Company manufactures the ViraTech UV-400, which utilizes high-intensity ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria, at rates exceeding 99.2% on a first-pass basis, while also reducing the concentrations of odors, and VOC's (volatile organic compounds, such as acetone, benzene, formaldehyde, etc.) The FDA has issued a coveted Class II medical listing that enables UV Flu Technologies to market the product as a medical device. For more information, visit: For sales:
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
UV Flu Technologies, Inc.
John J. Lennon, President & CEO
Investor Information:
Geaux IR Services, Inc.
Toll-Free: 1-888-355-8838
SOURCE: UV Flu Technologies, Inc.
UV Flu Technologies (OTCBB: UVFT) is a showcase biotech stock on (please read disclosure and disclaimers)
Visit the showcase page on

Request info:

No comments:

Post a Comment